Showing results (191-200 of 356) with videos related to
Sort By:
Pageof 36
Cell Cycle (Georgetown, Tex.)|February 20, 2015
Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristicsShumei Kato, Maria Schwaederle, Gregory A Daniels, et al.Cureus|November 16, 2022
Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.Scientific Reports|May 17, 2020
Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancerAnton Cheltsov, Natsuko Nomura, Venkata M Yenugonda, et al.International Medical Case Reports Journal|December 22, 2022
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001Terese Catherine Hammond, Raymond C Lee, Bryan Oronsky, et al.Journal of Translational Medicine|November 18, 2023
Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccinesFeng Lin, Emma Z Lin, Misa Anekoji, et al.Journal of Translational Medicine|December 26, 2022
MTAP loss: a possible therapeutic approach for glioblastomaC Pawan K Patro, Nupur Biswas, Sandeep C Pingle, et al.Plos One|February 27, 2013
High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical modelsShawn E Yost, Sandra Pastorino, Sophie Rozenzhak, et al.Neuro-Oncology Advances|November 3, 2021
Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial dataDaniela A Bota, Warren Mason, Santosh Kesari, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 12, 2023
Therapy of autoimmune inflammation in sporadic amyotrophic lateral sclerosis: Dimethyl fumarate and H-151 downregulate inflammatory cytokines in the cGAS-STING pathwayKurosh Zamiri, Santosh Kesari, Ketema Paul, et al.Journal of Neuro-Oncology|December 2, 2008
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant gliomaAndrew D Norden, Jan Drappatz, Alona Muzikansky, et al.Pageof 36